Published in
Elsevier, The Lancet Oncology, 7(23), p. e318, 2022
DOI: 10.1016/s1470-2045(22)00331-x
Links
Tools
Optimal molecular selection to benefit from nivolumab–ipilimumab in clear-cell renal cell carcinoma
Journal article published in 2022 by
Yann-Alexandre Vano,
Réza Elaidi,
Letuan Phan,
Wolf Herman Fridman,
Catherine Sautès-Fridman,
Stéphane Oudard 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 